These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Wijelath ES; Rahman S; Namekata M; Murray J; Nishimura T; Mostafavi-Pour Z; Patel Y; Suda Y; Humphries MJ; Sobel M Circ Res; 2006 Oct; 99(8):853-60. PubMed ID: 17008606 [TBL] [Abstract][Full Text] [Related]
11. A catalytic role of heparin within the extracellular matrix. Mitsi M; Forsten-Williams K; Gopalakrishnan M; Nugent MA J Biol Chem; 2008 Dec; 283(50):34796-807. PubMed ID: 18845539 [TBL] [Abstract][Full Text] [Related]
12. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Adya R; Tan BK; Punn A; Chen J; Randeva HS Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells. Amemiya T; Sasamura H; Mifune M; Kitamura Y; Hirahashi J; Hayashi M; Saruta T Kidney Int; 1999 Dec; 56(6):2055-63. PubMed ID: 10594781 [TBL] [Abstract][Full Text] [Related]
14. Angiogenic response of endothelial cells to heparin-binding domain of fibronectin. Viji RI; Kumar VB; Kiran MS; Sudhakaran PR Int J Biochem Cell Biol; 2008; 40(2):215-26. PubMed ID: 17766169 [TBL] [Abstract][Full Text] [Related]
15. Facilitated diffusion of VEGF165 through descemet's membrane with sucrose octasulfate. Fannon M; Forsten-Williams K; Zhao B; Bach E; Parekh PP; Chu CL; Goerges-Wildt AL; Buczek-Thomas JA; Nugent MA J Cell Physiol; 2012 Nov; 227(11):3693-700. PubMed ID: 22378222 [TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors: evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains. Zhang W; Swanson R; Xiong Y; Richard B; Olson ST J Biol Chem; 2006 Dec; 281(49):37302-10. PubMed ID: 17040907 [TBL] [Abstract][Full Text] [Related]